The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Modified deoxyoligonucleotides stable to exonuclease degradation in serum
Open accessAbstract
Unmodified deoxyoligonucleotides are rapidly degraded in serum-containing medium. Utilizing internally labelled deoxyoligonucleotides the deoxyribonuclease profile for fetal calf serum and human serum was determined. It was found that the predominate nuclease activity in both systems was 3' exonuclease. Deoxyoligonucleotides are protected from exonuclease degradation in sera and cell media by simple terminal modifications that maintain high binding activity for the complementary DNA sequence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of Biochemistry and Molecular Biology
(2010) · CRC Press eBooks · doi:10.1201/b10501 · Cited by 803
Physicochemical properties of phospborothioate oligodeoxynucleotides
Stein, C. A., Subasinghe, C., Shinozuka, K., & Cohen, J. S. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.8.3209 · Cited by 591
Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M., Cohen, J. S., & Broder, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7706 · Cited by 533
Synthesis of DNA via deoxynudeoside H-phosphonate Intermediates
Froehler, B. C., Ng, P. G., & Matteucci, M. D. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.13.5399 · Cited by 347
Self-citationMatsukura, M., Zon, G., Shinozuka, K., Robert-Guroff, M., Shimada, T., Stein, C. A., Mitsuya, H., Wong-Staal, F., Cohen, J. S., & Broder, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4244 · Cited by 262
van de Sande, J. H., Ramsing, N. B., Germann, M. W., Elhorst, W., Kalisch, B. W., v. Kitzing, E., Pon, R. T., Clegg, R. C., & Jovin, T. M. (1988) · Science · doi:10.1126/science.3399890 · Cited by 230
A Quantitative Bioassay for HIV-1 Based on Trans-Activation
Felber, B. K., & Pavlakis, G. N. (1988) · Science · doi:10.1126/science.3422113 · Cited by 176
Woolf, T. M., Jennings, C. G. B., Rebagliati, M. R., & Melton, D. A. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.7.1763 · Cited by 157
Phosphoramidate analogues of DNA: synthesis and thermal stability of heteroduplexes
Froehler, B. C., Ng, P. G., & Matteucci, M. D. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.11.4831 · Cited by 110
Self-citationTidd, D., & Warenius, H. M. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.283 · Cited by 108
Cited by
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Gene inhibition using antisense oligodeoxynucleotides
Wagner, R. W. (1994) · Nature · doi:10.1038/372333a0 · Cited by 736
Röthlisberger, P., & Hollenstein, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.007 · Cited by 413
Nuclease resistance of DNA nanostructures
Chandrasekaran, A. R. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00251-y · Cited by 382
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081683 · Cited by 321
Progress in Antisense Oligonucleotide Therapeutics
Crooke, S. T., & Bennett, C. F. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000543 · Cited by 319
Single-nucleotide polymorphisms can cause different structural folds of mRNA
Shen, L. X., Basilion, J. P., & Stanton, V. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7871 · Cited by 317
The synthesis of modified oligonucleotides by the phosphoramidite approach and their applications
Beaucage, S. L., & Iyer, R. P. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)87958-8 · Cited by 317
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Adachi, T., & Nakamura, Y. (2019) · Molecules · doi:10.3390/molecules24234229 · Cited by 300
“Inverted deoxythymidine (idT), which has a 3′–3′ linkage, is widely used to prevent 3′–5′ exonuclease activity [40].”
Targeted tumor therapy with the TGF-β2 antisense compound AP 12009
SCHLINGENSIEPEN, K., SCHLINGENSIEPEN, R., STEINBRECHER, A., HAU, P., BOGDAHN, U., FISCHERBLASS, B., & JACHIMCZAK, P. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.002 · Cited by 195
Belletti, S., Uggeri, J., Gatti, R., Govoni, P., & Guizzardi, S. (2007) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2007.00320.x · Cited by 38
Metadata
- Authors
- Shaw, J.-P., Kent, K., Bird, J., Fishback, J., & Froehler, B.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1991
- Volume
- 19
- Issue
- 4
- Pages
- 747-750
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2006727124
- Cited by
- 369
- References
- 12
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.